SEARCH

SEARCH BY CITATION

References

  • 1
    Somech R, Simon AJ, Lev A et al. Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells. J Allergy Clin Immunol 2009; 124:793800.
  • 2
    Villa A, Santagata S, Bozzi F et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998; 93:885896.
  • 3
    Santagata S, Gomez CA, Sobacchi C et al. N-terminal RAG1 frameshift mutations in Omenn's syndrome: internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains. Proc Natl Acad Sci USA 2000; 97:1457214577.
  • 4
    Villa A, Notarangelo LD, Roifman CM. Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol 2008; 122:10821086.
  • 5
    Cavadini P, Vermi W, Facchetti F et al. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest 2005; 115:728732.
  • 6
    Plebani A, Stringa M, Prigione I et al. Engrafted maternal T cells in human severe combined immunodeficiency: evidence for a TH2 phenotype and a potential role of apoptosis on the restriction of T-cell receptor variable beta repertoire. J Allergy Clin Immunol 1998; 101:131134.
  • 7
    Lev A, Simon AJ, Trakhtenbrot L et al. Characterizing T cells in SCID patients presenting with reactive or residual T lymphocytes. Clin Dev Immunol 2012; 2012:261470.
  • 8
    Aleman K, Noordzij JG, de Groot R, van Dongen JJ, Hartwig NG. Reviewing Omenn syndrome. Eur J Pediatr 2001; 160:718725.
  • 9
    Cattaneo F, Recher M, Masneri S et al. Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment. J Allergy Clin Immunol 2013; 131:11361145.
  • 10
    Shearer WT, Dunn E, Notarangelo LD et al. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol 2013. pii: S0091-6749 (13) 01495-4. doi: 10.1016/j.jaci.2013.09.044.
  • 11
    Müller SM, Ege M, Pottharst A, Schulz AS, Schwarz K, Friedrich W. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 2001; 98:18471851.
  • 12
    Tezcan I, Ersoy F, Sanal O et al. Long-term survival in severe combined immune deficiency: the role of persistent maternal engraftment. J Pediatr 2005; 146:137140.
  • 13
    Palmer K, Green TD, Roberts JL et al. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency. J Allergy Clin Immunol 2007; 120:423428.
  • 14
    Touzot F, Dal-Cortivo L, Verkarre V et al. Massive expansion of maternal T cells in response to EBV infection in a patient with SCID-Xl. Blood 2012; 120:19571959.
  • 15
    Denianke KS, Frieden IJ, Cowan MJ, Williams ML, McCalmont TH. Cutaneous manifestations of maternal engraftment in patients with severe combined immunodeficiency: a clinicopathologic study. Bone Marrow Transplant 2001; 28:227233.